These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14226831)

  • 1. [MUTAGENIC AND CANCERIGENIC ACTIONS OF ALKYLATING AGENTS].
    VERLY WG
    Rev Fr Etud Clin Biol; 1964 Oct; 9():878-83. PubMed ID: 14226831
    [No Abstract]   [Full Text] [Related]  

  • 2. [INFLUENCE OF ALKYLATING ANTINEOPLASTIC AGENTS ON NARCOSIS].
    DIMEZZA F
    Minerva Anestesiol; 1964 Dec; 30():511-7. PubMed ID: 14267928
    [No Abstract]   [Full Text] [Related]  

  • 3. THE BONE-MARROW DEPRESSANT AND ANTITUMOR PROPERTIES IN ANIMALS OF SOME NEW ALKYLATING AGENTS.
    FINLEY WH; CARLSON WW; FROMMEYER WB; WOODS JW
    Cancer; 1964 Oct; 17():1271-7. PubMed ID: 14236760
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on chemical carcinogens and mutagens. XXXVI. Apparent activation energy from mutagenic modification induced in E. coli by alkylating agents. Estimation from mutation frequency.
    Hakura A; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1728-34. PubMed ID: 3521919
    [No Abstract]   [Full Text] [Related]  

  • 5. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 6. DENTAL LESIONS IN RAT INDUCED BY RADIOMIMETIC AGENTS.
    HEBBORN P; MISHRA LC; DALTON C; WILLIAMS JP
    Arch Pathol; 1965 Aug; 80():110-5. PubMed ID: 14326433
    [No Abstract]   [Full Text] [Related]  

  • 7. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
    [No Abstract]   [Full Text] [Related]  

  • 8. THE EFFECTS OF ALKYLATING AGENTS ON FERTILITY.
    JACKSON H
    Br Med Bull; 1964 May; 20():107-14. PubMed ID: 14171898
    [No Abstract]   [Full Text] [Related]  

  • 9. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells.
    Sanderson BJ; Johnson KJ; Henner WD
    Environ Mol Mutagen; 1991; 17(4):238-43. PubMed ID: 2050131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUTAGENIC EFFECTS OF HYDROXYLAMINE IN VIVO.
    TESSMAN I; ISHIWA H; KUMAR S
    Science; 1965 Apr; 148(3669):507-8. PubMed ID: 14263771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE TOXICOLOGY OF CHEMOSTERILANTS.
    HAYES WJ
    Bull World Health Organ; 1964; 31(5):721-36. PubMed ID: 14278008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 14. THE LETHAL AND MUTAGENIC EFFECTS OF N-NITROSO-N-METHYL-URETHANE AND N-NITROSO-N-ETHYLURETHANE IN COLLETOTRICHUM COCCODES.
    LOPRIENO N; ZETTERBERG G; GUGLIELMINETTI R; MICHEL E
    Mutat Res; 1964 May; 106():37-44. PubMed ID: 14195749
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE MUTATION SPECTRUM OF ORGAN-SPECIFIC CANCEROGENIC SUBSTANCES].
    KUENKEL HA
    Krebsforsch Krebsbekampf; 1964; 30():138-42. PubMed ID: 14283699
    [No Abstract]   [Full Text] [Related]  

  • 16. [VARIATION IN VITAMIN PRODUCTION BY ACT. OLIVACEUS INDUCED BY NEW MUTAGENS OF THE 2-CHLORALKYL SERIES].
    OGANESIAN MG; ALIKHANIAN SI
    Antibiotiki; 1964 Jan; 9():22-4. PubMed ID: 14191793
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92.
    Seino Y; Nagao M; Yahagi T; Hoshi A; Kawachi T; Sugimura T
    Cancer Res; 1978 Jul; 38(7):2148-56. PubMed ID: 350383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROTOZOA AS TOXICOLOGIC TOOLS.
    HUTNER SH
    J Protozool; 1964 Feb; 11():1-6. PubMed ID: 14119556
    [No Abstract]   [Full Text] [Related]  

  • 19. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE CARCINOSTATIC EFFECTS OF AMINOALKYLATING COMPOUNDS. 1. ON CYTOSTATICS].
    SCHOENENBERGER H; ADAM A
    Arzneimittelforschung; 1964 Oct; 14():1168. PubMed ID: 14343486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.